Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (4): 358-364.DOI: 10.3969/j.issn.1673-8640.2025.04.008
Previous Articles Next Articles
LI Hu, ZHU Weinan, CHEN Feng, WANG Jiawei, LIU Ying, SHEN Lisong, ZHENG Yingxia()
Received:
2024-07-08
Revised:
2024-10-18
Online:
2025-04-30
Published:
2025-05-08
CLC Number:
LI Hu, ZHU Weinan, CHEN Feng, WANG Jiawei, LIU Ying, SHEN Lisong, ZHENG Yingxia. Molecular characteristics and virulence analysis of hypermucoviscous carbapenem-resistant Klebsiella pneumonia[J]. Laboratory Medicine, 2025, 40(4): 358-364.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.04.008
抗菌药物 | 总体 (96株) | 携带blaKPC-2的HM-CRKP(86株) | 不携带blaKPC-2的HM-CRKP(10株) |
---|---|---|---|
头孢呋辛 | 100.0 | 100.0 | 100.0 |
头孢噻肟 | 100.0 | 100.0 | 100.0 |
头孢曲松 | 100.0 | 100.0 | 100.0 |
头孢他啶 | 99.0 | 100.0 | 90.0 |
头孢吡肟 | 95.8 | 98.8 | 70.0* |
头孢美唑 | 95.8 | 98.8 | 70.0* |
氨苄西林-舒巴坦 | 100.0 | 100.0 | 100.0 |
亚胺培南 | 100.0 | 100.0 | 100.0 |
美罗培南 | 100.0 | 100.0 | 100.0 |
庆大霉素 | 81.3 | 89.5 | 10.0* |
阿米卡星 | 80.2 | 88.4 | 10.0* |
左氧氟沙星 | 92.7 | 100.0 | 30.0* |
环丙沙星 | 92.7 | 100.0 | 30.0* |
复方磺胺甲噁唑 | 59.4 | 65.1 | 10.0* |
替加环素 | 0.0 | 0.0 | 0.0 |
抗菌药物 | 总体 (96株) | 携带blaKPC-2的HM-CRKP(86株) | 不携带blaKPC-2的HM-CRKP(10株) |
---|---|---|---|
头孢呋辛 | 100.0 | 100.0 | 100.0 |
头孢噻肟 | 100.0 | 100.0 | 100.0 |
头孢曲松 | 100.0 | 100.0 | 100.0 |
头孢他啶 | 99.0 | 100.0 | 90.0 |
头孢吡肟 | 95.8 | 98.8 | 70.0* |
头孢美唑 | 95.8 | 98.8 | 70.0* |
氨苄西林-舒巴坦 | 100.0 | 100.0 | 100.0 |
亚胺培南 | 100.0 | 100.0 | 100.0 |
美罗培南 | 100.0 | 100.0 | 100.0 |
庆大霉素 | 81.3 | 89.5 | 10.0* |
阿米卡星 | 80.2 | 88.4 | 10.0* |
左氧氟沙星 | 92.7 | 100.0 | 30.0* |
环丙沙星 | 92.7 | 100.0 | 30.0* |
复方磺胺甲噁唑 | 59.4 | 65.1 | 10.0* |
替加环素 | 0.0 | 0.0 | 0.0 |
碳青霉烯酶基因 | 2015年 (142株) | 2016年 (271株) | 2017年 (264株) | 2018年 (361株)① | 2019年 (291株) | 2020年 (353株)② |
---|---|---|---|---|---|---|
blaKPC-2 | 1(0.7) | 2(0.7) | 6(2.3) | 11(3.0) | 24(8.2) | 42(11.9) |
blaKPC-3 | 0(0.0) | 0(0.0) | 1(0.4) | 0(0.0) | 0(0.0) | 0(0.0) |
blaNDM-1 | 0(0.0) | 0(0.0) | 1(0.4) | 2(0.6) | 0(0.0) | 0(0.0) |
blaIMP-4 | 0(0.0) | 0(0.0) | 0(0.0) | 5(1.4) | 1(0.3) | 0(0.0) |
碳青霉烯酶基因 | 2015年 (142株) | 2016年 (271株) | 2017年 (264株) | 2018年 (361株)① | 2019年 (291株) | 2020年 (353株)② |
---|---|---|---|---|---|---|
blaKPC-2 | 1(0.7) | 2(0.7) | 6(2.3) | 11(3.0) | 24(8.2) | 42(11.9) |
blaKPC-3 | 0(0.0) | 0(0.0) | 1(0.4) | 0(0.0) | 0(0.0) | 0(0.0) |
blaNDM-1 | 0(0.0) | 0(0.0) | 1(0.4) | 2(0.6) | 0(0.0) | 0(0.0) |
blaIMP-4 | 0(0.0) | 0(0.0) | 0(0.0) | 5(1.4) | 1(0.3) | 0(0.0) |
[1] | JIN M, JIA T, LIU X, et al. Clinical and genomic analysis of hypermucoviscous Klebsiella pneumoniae isolates:identification of new hypermucoviscosity associated genes[J]. Front Cell Infect Microbiol, 2023, 12:1063406. |
[2] |
胡付品, 郭燕, 朱德妹, 等. 2021年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2022, 22(5):521-530.
DOI |
[3] | SUAY-GARCÍA B, PÉREZ-GRACIA M T. Present and future of carbapenem-resistant Enterobacteriaceae(CRE)infections[J]. Antibiotics(Basel), 2019, 8(3):122. |
[4] | SHI Y, PENG Y, ZHANG Y, et al. Safety and efficacy of a phage,kpssk3,in an in vivo model of carbapenem-resistant hypermucoviscous Klebsiella pneumoniae bacteremia[J]. Front Microbiol, 2021, 12:613356. |
[5] | ZHAN L, WANG S, GUO Y, et al. Outbreak by hypermucoviscous Klebsiella pneumoniae ST11 isolates with carbapenem resistance in a tertiary hospital in China[J]. Front Cell Infect Microbiol, 2017, 7:182. |
[6] | WANG Q, CHEN M, OU Q, et al. Carbapenem-resistant hypermucoviscous Klebsiella pneumoniae clinical isolates from a tertiary hospital in China:antimicrobial susceptibility,resistance phenotype,epidemiological characteristics,microbial virulence,and risk factors[J]. Front Cell Infect Microbiol, 2022, 12:1083009. |
[7] | GU D, DONG N, ZHENG Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital:a molecular epidemiological study[J]. Lancet Infect Dis, 2018, 18(1):37-46. |
[8] | ALTAYB H N, ELBADAWI H S, BAOTHMAN O, et al. Genomic analysis of multidrug-resistant hypervirulent(hypermucoviscous) Klebsiella pneumoniae strain lacking the hypermucoviscous regulators(rmpA/rmpA2)[J]. Antibiotics(Basel), 2022, 11(5):596. |
[9] | Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100Ed33,CLSI, 2023. |
[10] | ZHU W, LIU Y, CHEN F, et al. Cooccurrence of antibiotic resistance and hypervirulence in high-risk carbapenem-resistant K14.K64 and wzi209 Klebsiella pneumoniae strains driven by plasmids and their derivatives[J]. Microbiol Spectr, 2022, 10(5):e0254121. |
[11] | XIANG Y, TIAN H, CHEN Q, et al. Clinical and molecular characteristics of Klebsiella pneumoniae infection in a tertiary general hospital of Wuhan,China[J]. Eur J Clin Microbiol Infect Dis, 2024, 43(2):269-278. |
[12] | 杜芳玲, 梅艳芳, 万腊根, 等. 高黏液型肺炎克雷伯菌荚膜血清分型及碳青霉烯类耐药机制研究[J]. 中国感染与化疗杂志, 2018, 18(3):278-285. |
[13] | ZHANG Y, JIN L, OUYANG P, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China:a multicentre,molecular epidemiological analysis[J]. J Antimicrob Chemother, 2020, 75(2):327-336. |
[14] | HAN R, SHI Q, WU S, et al. Dissemination of carbapenemases(KPC,NDM,OXA-48,IMP,and VIM)among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China[J]. Front Cell Infect Microbiol, 2020, 10:314. |
[15] | YIN L, YAN G, LU L, et al. Molecular characteristics and virulence factors of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai,China[J]. Infect Genet Evol, 2023, 112:105451. |
[16] | DOS ANJOS C, SABINO C P, SELLERA F P, et al. Hypervirulent and hypermucoviscous strains of Klebsiella pneumoniae challenged by antimicrobial strategies using visible light[J]. Int J Antimicrob Agents, 2020, 56(1):106025. |
[17] | PEERMOHAMED S, KOGILWAIMATH S. Hypervirulent(hypermucoviscous) Klebsiella pneumoniae causing pyogenic liver abscess[J]. CMAJ, 2018, 190(14):E441. |
[18] | LI G, SHI J, ZHAO Y, et al. Identification of hypervirulent Klebsiella pneumoniae isolates using the string test in combination with Galleria mellonella infectivity[J]. Eur J Clin Microbiol Infect Dis, 2020, 39(9):1673-1679. |
[19] | YANG X, SUN Q, LI J, et al. Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China[J]. Emerg Microbes Infect, 2022, 11(1):841-849. |
[20] | KOCHAN T J, NOZICK S H, VALDES A, et al. Klebsiella pneumoniae clinical isolates with features of both multidrug-resistance and hypervirulence have unexpectedly low virulence[J]. Nat Commun, 2023, 14(1):7962. |
[21] | OUYANG P, JIANG B, PENG N, et al. Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital[J]. J Clin Lab Anal, 2022, 36(6):e24476. |
[22] | ZHU J, JIANG X, ZHAO L, et al. An outbreak of ST859-K19 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese teaching hospital[J]. mSystems, 2022, 7(3):e0129721. |
[23] | ALI M R, YANG Y, DAI Y, et al. Prevalence of multidrug-resistant hypervirulent Klebsiella pneumoniae without defined hypervirulent biomarkers in Anhui,China:a new dimension of hypervirulence[J]. Front Microbiol, 2023, 14:1247091. |
[1] | GUO Chaonan, WANG Yanyan, ZHANG Bei, PANG Jingying, CUI Feifei, ZHAO Yongxin, SU Bing. Analysis of drug resistance and virulence of Klebsiella pneumoniae from different clinical samples [J]. Laboratory Medicine, 2024, 39(9): 880-887. |
[2] | WU Xinzhe, MAO Haifeng, YANG Jin, ZUO Chunlei, JIN Danting. Clinical application of MALDI-TOF direct droplet culture method in rapid determination of CRKP [J]. Laboratory Medicine, 2024, 39(6): 587-591. |
[3] | SUN Miaoli, WU Qiong, WANG Yingzhi, WANG Jianqiang, GAO Feng, TANG Jin. Research progress on determination and treatment of carbapenem-resistant Klebsiella pneumoniae [J]. Laboratory Medicine, 2024, 39(6): 615-620. |
[4] | YU Feng, HU Longhua, XIAO Yanping, YANG Junping. Virulence genes and molecular characteristics of Klebsiella pneumoniae isolated from bloodstream infection patients [J]. Laboratory Medicine, 2024, 39(3): 249-255. |
[5] | ZHOU Ning, MAO Min, JI Xin, HE Jiale, YE Xiuyun, LIN Yubo, ZHONG Wei, LIU Yang. Etiology and molecular analysis of Streptococcus suis type 14 causing sepsis, meningitis and pneumonia [J]. Laboratory Medicine, 2024, 39(11): 1042-1047. |
[6] | ZHU Yanyan, YAN Zelin, WU Yuchen, ZHANG Yanyan, ZHANG Rong. Epidemiology,drug resistance and virulence gene analysis of Clostridium perfringens in different populations [J]. Laboratory Medicine, 2024, 39(10): 985-992. |
[7] | ZHU Yurong, ZHANG Dan, HE Yaxing, LI Jingjing, HUANG Jing, LI Ting, LIU Peng, LIU Ronghua. Classification and epidemiology characteristics of Klebsiella pneumoniae isolated from clinic [J]. Laboratory Medicine, 2023, 38(5): 435-440. |
[8] | FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes [J]. Laboratory Medicine, 2023, 38(4): 357-361. |
[9] | WANG Jiawei, ZHU Weinan, CHEN Yingying, JI Ping, WANG Ying. Clinical characteristics,molecular typing and drug resistance genes of carbapenem-resistant Klebsiella pneumoniae isolated from blood culturing [J]. Laboratory Medicine, 2023, 38(4): 362-367. |
[10] | DENG Chen, DAI Jiaze, QIU Lihong, SHEN Weiting, CAI Mufa, LUO Wenying. Molecular epidemic characteristics of hypervirulent Klebsiella pneumoniae in Zhanjiang [J]. Laboratory Medicine, 2023, 38(11): 1026-1031. |
[11] | WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu. Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae [J]. Laboratory Medicine, 2023, 38(1): 81-86. |
[12] | PAN Yunqi, LI Yungai, WANG Jianqiang, WU Qiong, TANG Jin. Analysis of molecular typing,virulence genes and antibiotic susceptibility of uropathogenic Escherichia coli in patients with recurrent urinary tract infection [J]. Laboratory Medicine, 2022, 37(2): 141-145. |
[13] | KANG Yi, ZHU Hong, SHEN Han, ZHOU Wanqing. Virulence gene analysis of Enterococcus isolated from clinical blood and urine samples [J]. Laboratory Medicine, 2022, 37(11): 1030-1033. |
[14] | HUANG Yun, LI Congrong. Research progress on hypervirulent Klebsiella pneumonia [J]. Laboratory Medicine, 2021, 36(11): 1181-1185. |
[15] | ZHOU Yanxia, JIN Dongfang. Inhibition and mechanism of tannic acid on biofilm formation in Klebsiella pneumoniae [J]. Laboratory Medicine, 2021, 36(10): 1070-1073. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||